Senestech, Inc. (SNES) Stock Rating Upgraded by Zacks Investment Research
Senestech, Inc. (NASDAQ:SNES) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday.
According to Zacks, “SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company’s fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. “
Shares of Senestech (SNES) traded up 1.19% on Tuesday, hitting $1.70. 6,920 shares of the company traded hands. The stock’s 50-day moving average price is $1.94 and its 200-day moving average price is $1.94. Senestech has a 12 month low of $1.54 and a 12 month high of $10.69. The company’s market capitalization is $17.55 million.
Senestech (NASDAQ:SNES) last released its quarterly earnings results on Thursday, August 10th. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.07). The company had revenue of $0.01 million for the quarter, compared to analysts’ expectations of $0.10 million. On average, equities analysts predict that Senestech will post ($1.30) earnings per share for the current year.
In other Senestech news, Director Julia Ann Williams purchased 10,000 shares of Senestech stock in a transaction that occurred on Wednesday, July 26th. The stock was purchased at an average price of $3.21 per share, for a total transaction of $32,100.00. Following the transaction, the director now directly owns 11,950 shares in the company, valued at $38,359.50. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Andrew Altman purchased 20,000 shares of Senestech stock in a transaction that occurred on Friday, August 18th. The stock was acquired at an average price of $2.77 per share, with a total value of $55,400.00. Following the transaction, the chief operating officer now owns 2,600 shares in the company, valued at $7,202. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 54,100 shares of company stock valued at $155,730 and sold 19,411 shares valued at $46,073. 27.40% of the stock is owned by corporate insiders.
A hedge fund recently bought a new stake in Senestech stock. White Pine Capital LLC purchased a new stake in Senestech, Inc. (NASDAQ:SNES) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 19,250 shares of the company’s stock, valued at approximately $110,000. White Pine Capital LLC owned about 0.19% of Senestech at the end of the most recent reporting period. 15.34% of the stock is owned by hedge funds and other institutional investors.
SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.
Receive News & Stock Ratings for Senestech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech Inc. and related stocks with our FREE daily email newsletter.